Intensity Therapeutics, Inc.
INTS • NASDAQ • Stock Fundamentals
Intensity Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lewis H. Bender, with a market cap of $9.9M.
Market Cap$9.9M
Employees17.0
CEOLewis H. Bender
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Intensity Therapeutics, Inc. FAQ
Common questions about Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc. (INTS) has a market capitalization of $9.9M and trades on NASDAQ.
Intensity Therapeutics, Inc. has approximately 17 employees.